Bimatoprost in the Treatment of Eyelash Hypotrichosis

The document reviewed the use of Bimatoprost for treating eyelash hypotrichosis, demonstrating its effectiveness in increasing eyelash length, thickness, and darkness. Clinical trials with 278 participants showed significant improvements, with 78% of patients experiencing noticeable changes. Bimatoprost worked by stimulating hair follicles to transition from the resting to the growing phase. Side effects were generally mild, including eye redness, itching, and hyperpigmentation, but more severe issues like cystoid macular edema and systemic effects such as respiratory infections and headaches were noted. Its effectiveness in treating eyelash alopecia areata was uncertain, and it required intact hair follicles to be effective. Despite potential risks, Bimatoprost was approved by the FDA and expected to be popular due to the cultural desire for enhanced eyelashes.